Research and Development

PacBio to collaborate with National Cancer Centre of Singapore on cancer profiling
By LabPulse.com staff writers
Sequencing firm PacBio has signed a research collaboration agreement with the National Cancer Centre of Singapore to advance cancer research by profiling the cancer types that are prevalent in Asia.
October 11, 2024
Dna Sequencing Data Analysis Social
Myriad Genetics enters 5 MRD test research collaborations
By LabPulse.com staff writers
Precision medicine company Myriad Genetics has entered into five ongoing research collaborations aimed at studying the use of molecular residual disease (MRD) testing in breast cancer using Myriad's Precise MRD test.
October 9, 2024
Breast Cancer2 Social
CAP, ADLM, NILA caution court in FDA LDT decisions
By Liz Carey
Organizations rally on deadline for amicus briefs.
October 9, 2024
Lab Tubes Pipette Social
Lumos gets $3M in from BARDA to support POC test submission
By LabPulse.com staff writers
Lumos has been awarded approximately $3 million from BARDA in support of the clinical study and regulatory submission for the company’s bacterial/nonbacterial point-of-care (POC) respiratory infection test.
October 7, 2024
Research Money Social
Owlstone, FDA's OSEL partner to develop VOC ID methods
By LabPulse.com staff writers
Owlstone Medical entered a research collaboration agreement with the FDA's Center for Devices and Radiological Health Office of Science and Engineering Laboratories (OSEL) to develop methods of identifying volatile organic compounds (VOCs) in breath.
September 30, 2024
Molecule Social
Cepheid partners with Fleming Initiative on antimicrobial resistance
By LabPulse.com staff writers
Diagnostics firm Cepheid has entered a partnership with the Fleming Initiative, a global collaboration established by the Imperial College Healthcare National Health Service Trust and Imperial College London to combat antimicrobial resistance.
September 26, 2024
Colorized scanning electron micrograph of methicillin-resistant Staphylococcus aureus (MRSA) bacteria (gold) interacting with a human neutrophil (red). Image captured at NIAID's Rocky Mountain Laboratories (RML) in Hamilton, Montana.
NIH establishes pandemic preparedness research network
By LabPulse.com staff writers
The U.S. National Institutes of Health (NIH) has established a pandemic preparedness research network for research on the pathogens that are most likely to threaten human health.
September 19, 2024
Infectious Diseases Research Social
Humana, UnitedHealthcare change Z-code requirements for molecular diagnostic test claims
By LabPulse.com staff writers
Among the tests in focus are certain RNA- and DNA-based tests.
September 19, 2024
Blood Test Samples Lab Social
Multiregional clinical trial data on FDA watch for U.S. applicability
By LabPulse.com staff writers
Pivotal trials drawing on foreign clinical data in focus.
September 16, 2024
Fda Sign Dc Social
Mount Sinai Health gets $3.26M NIH grant for undiagnosed diseases center
By LabPulse.com staff writers
Mount Sinai Health received a four-year, $3.26 million grant from the U.S. National Institutes of Health (NIH) to establish the new Mount Sinai Center for Undiagnosed Diseases, the first Undiagnosed Diseases Network site in the New York metropolitan area.
September 17, 2024
Sequencing Dna Rna Social
HudsonAlpha Institute gets $2.9M NIH grant for pediatric rare disease sequencing
By LabPulse.com staff writers
Scientists at the HudsonAlpha Institute for Biotechnology in Huntsville, AL, have been awarded a five-year, $2.9 million U.S. National Institutes of Health (NIH) grant to identify genetic contributors to rare diseases in children.
September 6, 2024
Dna Sequencing Data Analysis Social
Seegene, Springer Nature launch PCR innovation program
By LabPulse.com staff writers
Molecular diagnostics firm Seegene and Springer Nature have launched a new project for the development of diagnostic assays, as part of their ongoing strategic partnership.
September 3, 2024
Research Money Social
Page 1 of 42
Next Page